Safety, Tolerability, and Pharmacokinetics of ACT500 in Healthy Adult Participants

Clinical trial NCT06716905 · COMPLETED

Trial details

NCT number: NCT06716905
Sponsor: Xiamen Amoytop Biotech Co., Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Non-alcoholic Steatohepatitis

Start date: 2025-03-06
Primary completion: 2025-09-22
Enrollment: 72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.